LINC Dubai 2015 Programme

Find all topics and speakers listed below.


» Download the programme as PDF file. 

Conference day 1

  • - , Main Arena

    Scrub in with the experts: Interventional treatment of aortoiliac TASC C and D lesions and in-stent restenosis

    Chairman:
    Dierk Scheinert
    Moderator:
    Martin Forlee
    live from University Hospital Leipzig, Germany:
    Andrej Schmidt
    1. -

      Advanced techniques for recanalization of TASC C/D aortoiliac lesions

        Sven Bräunlich
  • - , Main Arena

    Latest advancements in DCB as standard of care for claudicant patients:IN.PACT update

    Chairman:
    Dierk Scheinert
    Moderators:
    Ayman Al-Sibaie, Martin Forlee
    1. -

      Latest level 1 clinical evidence update: insights from IN.PACT SFA trial

        Antonio Micari
    2. -

      IN.PACT clinical performances in real world patients population

        Samer Koussayer
    3. -

      Does IN.PACT DCB work in long lesions?

        Thomas Zeller
    4. -

      IN.PACT DCB is effective for long term: Insights from Italian registry and personal experience

        Antonio Micari
    5. -

      Discussion and conclusion

  • - , Main Arena

    Symposium: Changing paradigms in femoro-popliteal interventions

    Chairman:
    Dierk Scheinert
    Moderators:
    Antonio Micari, Thomas Zeller
    1. -

      Live case transmission from University Hospital Leipzig, Germany

    2. -

      Update on the LEVANT II clinical trial programme

        Dierk Scheinert
    3. -

      The Stellarex DCB technology and clinical evidence

        Antonio Micari
    4. -

      DCB outcomes – what part does technology play?

        Arne Schwindt
    5. -

      Live case transmission from University Hospital Leipzig, Germany

    6. -

      What works best long term in complex femoropopliteal disease? The Leipzig experience with DCB, conventional, and interwoven nitinol stents

        Sabine Steiner, Via satellite from Leipzig
    7. -

      Could combination DCB+stent be the answer in complex SFA lesions?

        Sven Bräunlich
    8. -

      Live case transmission from University Hospital Leipzig, Germany

    9. -

      A proposed treatment algorithm for focal and complex femoropopliteal disease implementing DCB, DES, atherectomy and uncoated devices

        Thomas Zeller
  • - , Main Arena

    Symposium: Drug eluting technologies: The final 5 year results

    Chairman:
    Thomas Zeller
    Moderators:
    Awais Siddique, Ayman Al-Sibaie, Sven Bräunlich
    1. -

      Zilver-PTX 5 year data

        Thomas Zeller
    2. -

      Live case transmission from University Hospital Leipzig, Germany

    3. -

      Zilver-PTX in my pratice

        Awais Siddique
    4. -

      How I use DES and DCB in my practice

        Ayman Al-Sibaie
    5. -

      European experience with the new delivery system

        Sven Bräunlich
    6. -

      Discussion and conclusion

  • - , Main Arena

    Lunch

  • - , Main Arena

    Scrub in with the experts: Advanced concepts for thrombus containing lesions

    Chairman:
    Dierk Scheinert
    Moderators:
    Sven Bräunlich, Steven Kum
    live from University Hospital Leipzig, Germany:
    Andrej Schmidt
    1. -

      Flash presentation: Mechanical trombectomy in peripheral arteries: The Leipzig experience in 1200+ patients

        Sven Bräunlich
    2. -

      Flash presentation: Mechanical trombectomy in peripheral arteries: The role of thrombectomy in in-stent-reocclusions

        Steven Kum
  • - , Main Arena

    Symposium: Advanced SFA intervention for durable outcomes

    Chairmen:
    Dierk Scheinert, Ayman Al-Sibaie
    Moderators:
    Mohammad AlTwalah, Mohammed Almoaiqel, Mohamed Sharkawy, Sherif Essam, Hazem Habboub
    1. -

      Long term durable outcomes with SUPERA and the economic implications

        Thomas Zeller
    2. -

      Live case transmission from University Hospital Leipzig, Germany

    3. -

      Middle East clinical experience with SUPERA

        Mohammad AlTwalah
    4. -

      Optimal implantation deployment for optimal outcomes with SUPERA

        Ayman Al-Sibaie
    5. -

      Panel discussion: atherectomy, DCB, SNS, covered, DES, SUPERA – so many new technologies – what is the evolving treatment algorithm for the SFA for durable long term outcomes?

  • - , Main Arena

    Critical limb ischemia treatment 2015: Lessons learned, current status and future perspectives

    Chairman:
    Giancarlo Biamino
    Moderators:
    Mohammad AlTwalah, Manar Trab, Arne Schwindt, Antonio Micari, Steven Kum
    1. -

      Real world CLI practice: Insights from the German CRITISCH registry

        Arne Schwindt
    2. -

      Endovascular management of diabetic foot in Kuwait

        Adel Ahmad
    3. -

      Live case transmission from University Hospital Leipzig, Germany

    4. -

      When is the angiosome concept the right concept and how to translate it into practice?

        Antonio Micari
    5. -

      BTK treatment strategies for diabetic foot

        Ahmed Haroun Abou Issa
    6. -

      Live case transmission from Policlinico Abano Terme, Italy

    7. -

      Aggressive BTK revascularization and advanced wound care: Patient specific therapy concepts

        Steven Kum
    8. -

      Making BTK results more durable: are DES and DCB the answer?

        Thomas Zeller
    9. -

      Live case transmission from University Hospital Leipzig, Germany

    10. -

      The Lutonix BTK clinical trial programme: status update and real world clinical experience

        Dierk Scheinert
    11. -

      Discussion and conclusion

  • - , Main Arena

    The next frontier: Venous interventions

    Chairman:
    Steven Kum
    Moderators:
    Ayman Al-Sibaie, Sherif Essam
    1. -

      DVT: Standard protocol in endovascular treatment of acute DVT

        Ayman Al-Sibaie
    2. -

      Illiac vein stenting in the context of acute ilio-femoral DVT

        Rashad Bishara
    3. -

      PTA & stenting for post thrombotic iliofemoral venous occlusive disease

        Sherif Essam
    4. -

      Discussion and conclusion

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. You are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and legal notice.

more info
  • Essential

    We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • Tracking

    We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • External Services

    Our website makes use of external services such as Issuu. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.